S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.08%) $0.926
USD/NOK
(-0.03%) $10.84
USD/GBP
(-0.09%) $0.792
USD/RUB
(-0.09%) $92.50

Realtime updates for ALK-Abelló A/S [AKABY]

Exchange: OTC Sector: Healthcare Industry: Biotechnology
Last Updated31 Dec 1970 @ 19:00

0.00% $ 90.00

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar...

Stats
Today's Volume 309.00
Average Volume 23.00
Market Cap 0.00
Last Dividend $0.145 ( 2017-03-15 )
Next Dividend $0 ( N/A )
P/E 3 000.00
ATR14 $0 (0.00%)

ALK-Abelló A/S Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ALK-Abelló A/S Financials

Annual 2021
Revenue: $3.92B
Gross Profit: $2.40B (61.18 %)
EPS: $0.200
Q2 2022
Revenue: $1.05B
Gross Profit: $641.00M (61.34 %)
EPS: $0.0381
Q1 2022
Revenue: $1.16B
Gross Profit: $739.00M (63.98 %)
EPS: $0.150
Q4 2021
Revenue: $1.10B
Gross Profit: $701.00M (63.79 %)
EPS: $0.0700

Financial Reports:

No articles found.

ALK-Abelló A/S Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

ALK-Abelló A/S Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.33 - good (83.35%) | Divividend Growth Potential Score: 2.89 - No dividend growth expected in the near future
Information
First Dividend $0.152 2015-03-25
Last Dividend $0.145 2017-03-15
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 3 --
Total Paid Out $0.448 --
Avg. Dividend % Per Year 0.00% --
Score 2.21 --
Div. Sustainability Score 8.33
Div.Growth Potential Score 2.89
Div. Directional Score 5.61 --
Next Divdend (Est)
(2024-12-30)
$0 Estimate 0.00 %
Dividend Stability
0.02 Very Bad
Dividend Score
2.21
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SHZHY Ex Dividend Knight 2023-09-11 Semi-Annually 0 0.00%
HKMPY Ex Dividend Knight 2023-08-11 Semi-Annually 0 0.00%
BCNAY Ex Dividend Knight 2023-05-12 Annually 0 0.00%
WTBFB Ex Dividend Junior 2023-09-07 Quarterly 0 0.00%
NODB Ex Dividend Junior 2023-10-17 Quarterly 0 0.00%
DWAHF Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
SWDBY Ex Dividend Junior 2023-03-31 Annually 0 0.00%
IPSEY Ex Dividend Knight 2023-06-02 Annually 0 0.00%
BTSDF No Dividend Player 2023-09-05 Annually 0 0.00%
PLDGP Ex Dividend Knight 2023-09-15 Quarterly 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.05591.5008.8810.00[0 - 0.5]
returnOnAssetsTTM0.03761.2008.7510.00[0 - 0.3]
returnOnEquityTTM0.06601.500-0.377-0.566[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.7350.8006.325.06[1 - 3]
quickRatioTTM0.1400.800-3.88-3.11[0.8 - 2.5]
cashRatioTTM0.1401.500-0.333-0.499[0.2 - 2]
debtRatioTTM0.122-1.5007.97-10.00[0 - 0.6]
interestCoverageTTM13.131.0006.256.25[3 - 30]
operatingCashFlowPerShareTTM0.4262.009.8610.00[0 - 30]
freeCashFlowPerShareTTM0.1862.009.9110.00[0 - 20]
debtEquityRatioTTM0.204-1.5009.18-10.00[0 - 2.5]
grossProfitMarginTTM0.6121.0003.143.14[0.2 - 0.8]
operatingProfitMarginTTM0.07711.000-0.458-0.458[0.1 - 0.6]
cashFlowToDebtRatioTTM0.6591.0007.457.45[0.2 - 2]
assetTurnoverTTM0.6720.8008.867.08[0.5 - 2]
Total Score8.33

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM3 127.161.00010.000[1 - 100]
returnOnEquityTTM0.06602.50-0.243-0.566[0.1 - 1.5]
freeCashFlowPerShareTTM0.1862.009.9410.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.4262.009.8610.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-22.591.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1201.0009.510[0.1 - 0.5]
Total Score2.89

ALK-Abelló A/S

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators